Cupricyclins, Novel Redox-Active Metallopeptides Based on Conotoxins Scaffold by Barba, Marco et al.
Cupricyclins, Novel Redox-Active Metallopeptides Based
on Conotoxins Scaffold
Marco Barba
1, Anatoli P. Sobolev
2, Veranika Zobnina
1, Maria Carmela Bonaccorsi di Patti
3, Laura
Cervoni
3, Maria Carolina Spiezia






1Department of Biology, University Roma Tre, Rome, Italy, 2Institute of Chemical Methodologies, CNR, Monterotondo Stazione, Italy, 3Department of Biochemical
Sciences, Sapienza University of Rome, Rome, Italy, 4Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita `, Rome, Italy, 5Department of Drug
Sciences and Technologies, Sapienza University of Rome, Rome, Italy, 6STAAM Department, University of Molise, Campobasso, Italy, 7National Institute of Nuclear
Physics, Roma Tre Section, Rome, Italy
Abstract
Highly stable natural scaffolds which tolerate multiple amino acid substitutions represent the ideal starting point for the
application of rational redesign strategies to develop new catalysts of potential biomedical and biotechnological interest.
The knottins family of disulphide-constrained peptides display the desired characteristics, being highly stable and
characterized by hypervariability of the inter-cysteine loops. The potential of knottins as scaffolds for the design of novel
copper-based biocatalysts has been tested by engineering a metal binding site on two different variants of an v-conotoxin,
a neurotoxic peptide belonging to the knottins family. The binding site has been designed by computational modelling and
the redesigned peptides have been synthesized and characterized by optical, fluorescence, electron spin resonance and
nuclear magnetic resonance spectroscopy. The novel peptides, named Cupricyclin-1 and -2, bind one Cu
2+ ion per molecule
with nanomolar affinity. Cupricyclins display redox activity and catalyze the dismutation of superoxide anions with an
activity comparable to that of non-peptidic superoxide dismutase mimics. We thus propose knottins as a novel scaffold for
the design of catalytically-active mini metalloproteins.
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Introduction
The rational redesign of (macro)molecules based on stable
scaffolds tolerant to multiple amino acid substitutions is a
powerful tool to develop novel catalysts with potential biomedical
and biotechnological applications [1–6]. A class of (macro)mol-
ecules which display these characteristics is the knottins family of
disulphide-constrained peptides [4]. These miniproteins, tipically
around 30 amino acids in length, share a peculiar knotted
topology of three disulfide bridges [7]. This topology is observed
in a number of evolutionary and functionally unrelated protein
families including plant protease inhibitors, cone snails, snakes
and spider toxins, and EGF-like domains [8]. The main structural
features of knottins are their stability to thermal denaturation,
resistance to proteolytic digestion, due to the cystine knot, their
small size, which makes feasible their production by chemical
synthesis, and a high tolerance to sequence variation of the
intercysteine loops [4]. Knottins thus represent optimal scaffolds
for redesign strategies aimed at developing novel metal-based
catalysts.
Among knottins, the highest tolerance to sequence variability is
observed in conotoxins, neurotoxic peptides from cone snails
venom, frequently cited as an example of natural combinatorial
chemistry [9].
In a previous study, we tested the potential of a natural 9 amino
acids-long, disulphide-constrained peptide, named Contryphan-
Vn [10–12], as a scaffold for the development of redox-active mini
metalloproteins by computational design of two variants carrying a
four-His copper binding site. The redesigned peptides, named
Cupryphans, were synthesized and characterized by a variety of
spectroscopic techniques, demonstrating that they selectively bind
Cu
2+ with a fairly high affinity and are endowed with superoxide
dismutase activity [5].
The present study extends the work carried out on Contryphan-
Vn to longer peptides, with the goal of finely modulating the
stability and the catalytic activity of the redesigned metalloproteins
by having a higher number of amino acid positions available to
substitution. In particular, we exploited the high tolerance of
conotoxins to multiple amino acid substitutions of to engineer a
copper binding site in two variants of an v-conotoxin. The design
procedure took into account the position-specific conservation of
the intercysteine loop residues in this family of peptides in order to
facilitate spontaneous achievement of the right fold. The rationale
behind this choice was that of keeping the composition of the
intercysteines loop as close as possible to that of the natural
sequences to favour loops conformations close to those observed in
v-conotoxins. Furthermore, the peculiarity of this work with
respect to other redesign strategies employing the knottins scaffold
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30739is that the four His metal ligands were introduced in the place of
four of the six Cys residues of the natural scaffold, with the aim of
avoiding multiple conformational isomers arising from incorrect
cysteine pairing during oxidative folding of the peptides.
Results and Discussion
Rational design of a copper binding miniprotein based
on conotoxins scaffold
The strategy employed in the present work to select a suitable
scaffold for engineering a mini metalloprotein was that of deriving
a consensus sequence from one of the most studied knottins
families, the O superfamily of conotoxins [13]. The rationale was
that of identyfing a scaffold with sequence/structural properties
common to all the members of the family and thus able to
spontaneously attain a stable fold. The amino acid sequence of one
of the members of this family, the v-conotoxin GVIA, which is
one of the best characterized in terms of both a function and
structure [14], was used as a bait in a PSI-BLAST [15] search of the
non redundant protein sequences database to recover all protein
sequences displaying a significant sequence similarity. The
recovered amino acid sequences were then aligned using the
ClustalW program [16], to obtain the multiple sequence alignment
shown in figure 1A. The three-dimensional structure is also
available for 6 out of the 18 conotoxins in the alignment, namely
v-conotoxin GVIA, v-conotoxin GVIA (O10K), v-conotoxin
MVIIC, v-conotoxin MVIIA, v-conotoxin So3 and the v-
conotoxin TxVII (PDB codes: 2CCO, 1TR6, 1OMN, 1OMG,
1FYG, 1F3K), thus facilitating the analysis of sequence/structure
relationships.
The multiple alignment was then analysed using the Weblogo
program [17] to obtain the graphic representation shown in
figure 1B, from which a consensus sequence of the v-conotoxins
was derived by choosing in each position of the sequence the most
frequent amino acid. The consensus sequence shown in figure 1B
was the starting point for the design. However, this sequence was
subsequently modified taking into account the following con-
straints: 1) the need to limit the hydrophobicity of the designed
peptide in order to avoid aggregation phenomena (this is why
Ala6, Met12, Gly25 and Gly28 where changed into Ser, Ser, Lys
and Tyr residues, the second most represented residues in those
positions according to the weblogo plot); 2) the need to introduce a
Trp probe in the designed peptide in order to measure the copper
binding affinity of the peptide using fluorescence quenching
techniques (this is why Tyr13 of the consensus sequence was
substituted by a Trp residue); 3) the need to constrain the
intercysteines loops and the C-terminal region of the peptide so as
to favour correct positioning of the His residues to generate the
Figure 1. Amino acid sequence alignment of v-conotoxins (A) and Weblogo [17] plot (B). The consensus sequence of the aligned v-
conotoxins is reported below the plot in panel B. The consensus sequence has been obtained by calculating the frequency of each amino acid in each
position of the amino acid sequence of the aligned v-conotoxin sequences using the Weblogo tool [17].
doi:10.1371/journal.pone.0030739.g001
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changed to Pro residues). With these changes to the consensus
sequence, the designed peptide accidentaly resulted to have a high
sequence similarity to our starting bait v-conotoxin GVIA
(Figure 2). Thus, v-conotoxin GVIA three-dimensional structure
was used to construct in silico the structural model of the first mini
metalloprotein variant (see Materials and Methods section for
details). One of the main problems connected with the folding of
conotoxins is the high probability of formation of multiple
disulphide bonds isomers of the mature peptides. It is well known
in fact that in vivo, folding of conotoxins occurs at the
prepropeptide stage (when the mature toxin sequence has two
additional sequence stretches at the N-terminus) and is aided by
protein disulphide isomerases [18]. In our case, to ensure that the
redesigned peptide folded in a unique structure, we substituted
four of the six cysteine residues of v-conotoxin GVIA with His
residues, after verifying that the interatomic distances of the
introduced His residues matched those observed in the Cu,Zn
superoxide dismutase copper site [19], taken as a template.
In particular, His residues were introduced in the place of Cys8,
Cys15, Cys19 and Cys26. These substitutions determine the
formation of a single disulphide bridge in the peptide structure,
avoiding problems due to the incorrect pairing of cysteine residues,
and hence favouring a unique folding of the redesigned peptide. At
the same time, binding of the metal to the four His ligands was
expected to constrain the polypeptide chain in a manner similar to
the two missing knotted disulphides. Furthermore, binding of
copper in a solvent shielded part of the molecule was expected to
facilitate the achievement of a higher superoxide dismutation rate
as demonstrated in Cu,Zn superoxide dismutase [20]. In fact, the
electrostatic steering effect of copper on the superoxide anion
substrate is enhanced if the copper charge is not screened by the
solvent [20].
The redesigned miniprotein, whose amino acid sequence is
shown in figure 2, has been named Cupricyclin-1 to emphasize the
presence of a copper binding site and the cyclization of the
polypeptide chain through one disulphide bond.
Molecular dynamics simulations of Cupricyclin-1
The structural model of Cupricyclin-1 was subjected to a 10 ns
molecular dynamics (MD) simulation run in explicit solvent to test
the stability of the introduced copper site and of the overall
structure (Figure 3). In detail, the solvated molecule was first
energy-minimized applying position restraints to all non-hydrogen
atoms. In this phase, the distances between the copper ion and the
Ne2 atoms of the four coordinating His residues were restrained to
a value of 2 A ˚ by using a harmonic potential (see Materials and
Methods section for details). Subsequently, 100 ps molecular
dynamics simulation under NVT conditions, followed by 100 ps
NPT simulation, with position restraints on all heavy atoms of the
miniprotein and with restrained copper-ligand binding distances,
were performed in order to equilibrate the temperature and
pressure of the system. In the following step the structure was
subjected to a 5 ns MD simulation with harmonic potentials
applied only to the distances between copper and its ligands, and
finally to a 10 ns MD simulation without any restraint. MD
simulations without restraints indicated that the redesigned
peptide can stably bind copper while preserving a well defined
structure. Detailed analysis of the position of the copper ion with
respect to the protein atoms of Cupricyclin-1 revealed that the
distances between copper and the nitrogen atoms of the four
ligands ranged from 2.0 to 2.5 A ˚ over the entire course of the
production run. Moreover, two additional ligands entered the
copper coordination sphere during the simulation: one water
molecule (metal-ligand distance 1.8–2.2 A ˚) and the carbonyl
oxygen of Trp13 (metal-ligand distance 2.0–2.5 A ˚). The coordi-
nation geometry of the copper ion remained octahedral during the
simulation time with an average angle between copper and each
pair of adjacent ligands of approx. 90u (values ranging from 88u to
93u). The Ne2 atoms of His8, His15, His26 and the carbonyl
oxygen of Trp13 lie in one plane, while the Ne2 atom of His19
and the water molecule are above and below the plane. This
coordination geometry is similar to that observed in Cu,Zn
superoxide dismutase (See Figure S1); indeed, a copper-coordi-
nating water molecule is also present in this enzyme [19].
Cupricyclin-1 synthesis and characterization
Cupricyclin-1 was synthesised by standard Fmoc chemistry,
loaded on a Vydac C18 semipreparative column and isolated from
by-products by HPLC. The major peptide-containing fraction was
then air oxidized at 0.01% concentration (w/w) in 0.1 M
NH4HCO3 to allow formation of the single disulphide bond.
The cyclic miniprotein was finally purified from dimers/multimers
by HPLC connected with an ESI-IT mass spectrometer and
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analysis.
The MALDI-TOF spectrum of Cupricyclin-1 shows a main
peak with a mass of 3154,00 a.m.u., corresponding to Cupricyclin-
1 in the cyclic oxidized form (See Figure S2A). To confirm this
result Cupricyclin-1 was treated either with the alkylating agent
iodoacetamide (IAM), or with dithiothreitol (DTT), or else with
both DTT and IAM. In the case of IAM treatment no
modification was observed in the MALDI-TOF spectrum profile
(Figure S2B), while the sample treated with DTT showed, as
expected, an increase of 2 a.m.u. of the main MALDI-TOF
spectrum peak, consistent with reduction of the two Cys residues
(Figure S2C). Finally, treatment with DTT followed by IAM
yielded a main peak centered at 3270 a.m.u., corresponding to the
alkylation of two Cys residues (mass increase +116 a.m.u.) (Figure
S2D).
Cupricyclin-1 metal binding ability
Evidence of Cu
2+ binding to Cupricyclin-1 was first obtained by
fluorescence quenching experiments, exploiting the ability of
copper ions to quench the fluorescence emitted by the single Trp
residue (Trp13) upon binding to the miniprotein [5,21].
Fluorescence quenching was dependent on metal concentration
and reached a maximum at a [Cu
2+]/[peptide] of approx. 1:1
(Figure 4). These characteristics are consistent with an energy-
transfer mechanism from the tryptophan residue to the copper
bound at the binding site. Fluorescence quenching due to copper
binding to Cupricyclin-1 was used to determine the binding
affinity of the miniprotein for Cu
2+. The fluorescence intensity
decrease at 352 nm as a function of increasing amounts of copper
ions was fitted with a non linear regression curve (Figure 4),
obtaining a copper dissociation constant of 3.8 (61.4)610
28 M.
Further evidence of copper-peptide binding was obtained by
optical spectroscopy analysis. Addition of a stoichiometric amount
of CuCl2 to Cupricyclin-1 (0.6 mM final concentration) induced
the appearance of absorption bands with maxima at 300–312 nm
and 520–600 nm (Figure 5), the first indicative of a Cu
2+-histidine
charge-transfer [22], the second due to electronic transitions of
copper d-d orbitals and typical of copper complexes with nitrogen
ligands [22,23]. The calculated molar extinction coefficient of
holo-Cupricyclin-1 at 595 nm is 203 M
21 cm
21.
The stability of the copper site of Cupricyclin-1 was also
investigated by differential scanning calorimetry (DSC). The DSC
trace of Cupricyclin-1 with bound copper exhibited a strong
exotherm beginning above 55uC and showing a minimum at
95uC. The exotherm disappeared after copper removal (see Figure
S3). No clear endotherm was evident in the thermograms, due to
the fact that the peptide almost completely lacks defined structural
elements which can yield DSC signals (such as hydrogen bonds).
In copper proteins such as azurin and plastocyanin, the exotherm
is attributed to copper-dependent redox reactions with cysteines
following copper release [24–26]. By analogy, DSC results indicate
that the metal site of Cupricyclin-1 is stable up to 55uC and that
copper release is complete only at 95uC (the T1/2 for copper
release being approx. 75uC). The stability of the copper site in
Cupricyclin-1 well compares with that of natural metalloproteins
such as azurin and plastocyanin which display complete copper
release at temperature values ranging from 70 to 85uC depending
on the metal oxidation state and the DSC scanning rate [24–26].
The fluorescent binding titration data suggested a copper:pep-
tide stoichiometry of 1:1. However this result would also be
compatible with the presence of higher cross-linked oligomers
where the copper:peptide ratio is 1:1 as well. To rule out this
possibility a MALDI-TOF spectrum of Cupricyclin-1 was
recorded, showing that only the apo and holo monomeric forms
of the peptide were present in the sample (see Figure S4).
EPR spectroscopy characterization of Cupricyclin-1
The liquid nitrogen EPR spectrum of Cupricyclin-1 (Fig. 6A,
spectrum ‘‘Cc-1’’) appeared to arise from two spectroscopically
distinguishable species of copper, as can be clearly seen by the split
peak of the low magnetic field hyperfine line (arrows). The EPR
parameters for a copper complex are determined by the chemical
composition and the physical constraints on the atoms nearest to
the metal ion, with g and A values strictly depending on the
composition of the ligand atoms bound to the copper. The EPR
spectrum of Cupricyclin-1, although heterogeneous, reveals an
essentially axial g tensor, with g// values in the range 2.21–2.25.
Figure 3. Three-dimensional model of Cupricyclin-1 before (A) and after MD simulations (B). The copper ion is represented by a green
sphere. For clarity only the His ligands, Trp13, the two Cys residues and the copper-coordinating water molecule are shown. The figure was prepared
using UCSF Chimera [53].
doi:10.1371/journal.pone.0030739.g003
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estimated to be above 0.018 cm
21. These values are typical of a
type-2 mono Cu(II) complex, i.e. a square planar ligation of the
copper ion with possible additional axial ligations [27]. The
empirical quotient f=g ///|A//| is considered an index of
tetrahedral distortion, ranging from 105 to 135 for square-planar
copper structures [28]. In this respect, the EPR parameters of
Cupricyclin-1 suggest a low degree of tetrahedral distortion. Also
worth of note is the absence of an anomalous number of lines in
the parallel region and of any half-field signal arising from a triplet
spin state, strongly supporting the hypothesis that the peptide is
monomeric in solution. All these data are fully consistent with the
coordination environment predicted by MD simulations. Variable
power experiments in the 2.5–190 mW range (not shown) did not
discriminate between the two signals, which had similar saturation
behavior, suggesting that the spectroscopic inhomogeneity could
arise from slightly different conformational states in a single copper
coordination environment.
Peisach and Blumberg showed that the g and A values in the
parallel region of the EPR spectrum of copper sites give
information on the type of ligating atoms [27]. According to their
method, the parameters of Cupricyclin-1 are in agreement with a
4-nitrogen coordination sphere. This is also consistent with the
nitrogen-induced superhyperfine splitting pattern observed in the
closely related Cupricyclin-2 (see below).
The metal-binding region of native SOD constitutes the
catalytic active site, therefore it is interesting to study in detail
Figure 4. Emission fluorescence spectra of Cupricyclin-1 in the presence of increasing amounts of Cu
2+ ions. (a) apo Cupricyclin-1
(0.5 mM); (b) a+CuCl2 0.06 mM; (c) a+CuCl2 0.12 mM; (d) a+CuCl2 0.18 mM; (e) a+CuCl2 0.24 mM; (f) a+CuCl2 0.30 mM; (g) a+CuCl2 0.36 mM; (h) a+CuCl2
0.41 mM and (i) a+CuCl2 0.51 mM (only the spectra relative to a stoichiometric ratio Cu
2+:Cupricyclin-1 #1 are reported); (inset): Determination of the
dissociation constant of Cu
2+ to Cupricyclin-1 by fluorescence quenching experiments. The non linear fitting curve of fluorescence decrease at
352 nm as function of increasing amounts of Cu
2+ ions is shown as a continuous line.
doi:10.1371/journal.pone.0030739.g004
Figure 5. Optical spectra of apo and holo Cupricyclin-1
(0.6 mM in 50 mM sodium acetate buffer, pH 6.5). The difference
spectrum is also shown to evidence the appearance of a band at 300–




PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e30739the metal sites of SOD-mimics in order to correlate the structure
to the biological behaviour. In the native enzyme, copper is
coordinated by three imidazole residues and a water molecule,
while an imidazolate bridge links the copper and zinc sites. This
results in a distorted tetrahedral structure of the copper site that
can be readily inferred from its strong anisotropic EPR signal [29]
with an f value of 159 for bovine Cu,Zn SOD [30]. The site is very
flexible, switching from an irregular pyramid containing one weak
axial water molecule in the oxidized form to a tricoordinated
conformation in its reduced form. This is a crucial aspect in that
high SOD activity is related to high flexibility in the conformation
around copper [31,32]. In this respect, the copper environment in
Cupricyclin-1 seems to be significantly more rigid, accounting for
its SOD activity that, although significant for a SOD-mimic (see
below), is still far from that of the native enzyme. It should also be
reminded that a five-coordinated square pyramidal or trigonal
bipyramidal structure is more favourable for a good SOD activity
than a four-coordinated square planar structure [33].
NMR spectroscopy characterization of Cupricyclin-1
Copper interaction with Cupricyclin-1 was also investigated by
NMR spectroscopy. The assignment of the
1H spectrum of apo-
Cupricyclin-1 is shown in Table 1. Copper interaction with apo-
Cupricyclin-1 was studied by addition of aliquots of CuSO4 to a
1.06610
23 M solution of the peptide in H2O/D2O (9:1 v/v). The
first CuSO4 addition (Cu
2+/peptide ratio 0.05:1) caused a drastic
broadening of Hd (between 7.0 and 6.9 ppm) and He proton
signals (between 7.7 and 7.6 ppm) of the imidazole rings of all four
histidine residues (see Figure 7). On the other hand, the signals of
Trp, Tyr and of other amino acid residues remained unchanged.
Stepwise addition of CuSO4 led to a further broadening of His
signals and to a decrease of the intensity and only minor
broadening of other
1H amino acid signals (Figure 7). At a
Cu
2+/peptide ratio higher than 1.0 a further broadening of all
1H
amino acid signals was observed.
These results suggest that at low Cu
2+/peptide ratios (#1), a
peptide–Cu
2+ complex is formed with a specific interaction
between the metal and all the four His residues of the peptide,
as indicated by the broadening of histidine signals. At high Cu
2+/
peptide ratios (.1), when the specific binding is already saturated,
a nonspecific interaction between Cu
2+ and other amino acid
residues is manifested by a further, minor, intensity decrease and
broadening of all the amino acid signals, as already observed in a
previous study from our lab on a structurally unrelated copper-
binding peptide [5].
Determination of superoxide dismutase activity of
Cupricyclin-1
The ability of the copper ion bound to Cupricyclin-1 to be
reversibly reduced, a prerequisite for any redox-mediated catalytic
activity, was tested by assaying the superoxide dismutase activity of
Cupricyclin-1 using the pyrogallol enzymatic assay [34]. From the
concentration of superoxide dismutase and Cupricyclin-1 required
to reach 50% inhibition of the reaction rate of pyrogallol
autoxidation (2.7610
29 M and 4.7610
25 M, respectively,




21) [35], a superoxide
dismutation rate of 1.8610
5 M
21 s
21 was calculated for Cupri-
cyclin-1, a value of the same order of magnitude of that observed
for Cupryphans [5] and for non peptidic superoxide dismutase
mimics [36].
Design and characterization of Cupricyclin-2
To study the role of peptide backbone flexibility in the metal
binding affinity and redox properties of Cupricyclins, an
additional variant was designed in which the intercysteines loop
residue Pro10 was substituted with an Ala residue and a Gly
residue was introduced between Arg17 and Ser18 to increase the
length of the loop connecting His15 to His19 (Figure 2C). The
structural properties of the novel peptide, named Cupricyclin-2,
were studied through a combination of MD simulations,
fluorescence, optical and EPR spectroscopy, and its superoxide
dismutase activity was determined. Molecular dynamics simula-
tions, carried out following the same protocol used for Cupricy-
clin-1, indicated that Cupricyclin-2 can stably bind copper in a
similar geometry as that observed for Cupricyclin-1. Also in the
case of Cupricyclin-2 the coordination geometry of the copper ion
remains octahedral during the time of the simulations, with the
nitrogen atoms of His8, His15 and His20 together with the
Figure 6. EPR spectrum of Cupricyclins. Panel A shows the
spectra of Cupricyclin-1 (Cc-1), Cupricyclin-2 (Cc-2) and a
difference spectrum (diff) obtained by arbitrarily subtracting
a fraction of Cc-1 from Cc-2. Arrows on the first hyperfine of Cc-1
reveals the signal heterogeneity. Experimental details in the text. Panel
B displays a detail of the perpendicular region of the difference
spectrum, shown both as the standard first derivative lineshape and as
the second derivative curve, to better evidence the superhyperfine lines
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atom of His27 and a water oxygen acting as apical ligands.
Comparative analysis of the MD simulations trajectories of
Cupricyclin-1 and Cupricyclin-2 indicated that, indeed, substitu-
tion Pro10Ala and insertion of Gly18 changed the conformational
stability and flexibility of the molecule as well as the pattern of
hydrogen bond interactions and of copper-protein interactions. A
decrease of the magnitude of conformational changes at the
beginning of the simulation, a higher flexibility over the course of
the production run as well as a decrease of the number of
hydrogen bonds of Cupricyclin-2 compared to Cupricyclin-1 were
observed.
Table 1. Assignments of
1H and
13C resonances of apo-Cupriknottin 1 in D2O at 300 K, pH 7.0.
Amino acid Atom Chemical shift (ppm)
Ca Cb,b9 Cc,c9 Cd Others
Asn 20






1H 4.33 1.83; 1.74 1.58 3.12
13C 55.2 29.4 25.8 42.0
Arg b
1H 4.26 1.65 1.49; 1.43 3.07
13C 54.6 29.8 25.7 42.0
Gly 3, 5
1H 3.95
13C4 4 . 1
His a
1H 4.62 3.10; 3.01 6.93
13C 55.3 30.0 118.8
His b
1H 4.52 3.08 6.91
13C 55.8 29.6 118.8
His c
1H 4.58 3.04; 2.97 6.89
13C 55.1 30.0 118.8
His d
1H 4.58 3.04; 2.98 6.87
13C 55.1 30.0 118.8
Lys 2, 4, 24
1H 4.25; 4.24; 4.19 1.64 1.36 2.94
13C 55.0; 55.5; 55.6 27.8 23.4 40.8
Pro 10
1H 4.35 2.26; 1.91 1.96 3.70
13C 62.6 30.8 26.1 49.4
Pro 21
1H 4.32 2.13; 1.65 1.85; 1.63 3.59
13C 62.2 30.6 25.5 49.3
Ser 6, 7, 9, 12, 18
1H 4.35; 4.41; 4.48 3.82
13C 57.8;57.3; 57.1 62.4
Thr a
1H 4.28 4.19 1.13
13C 60.8 68.2 20.3
Thr b
1H 4.25 4.15 1.17
13C 60.6 68.5 20.3
Trp 13
1H 4.66 3.26; 3.21 7.19 7.56 (He); 7.21 (Hf3); 7.12 (Hg); 7.46 (Hf2)
13C 56.2 28.1 125.8 119.7 (Ce); 123.4 (Cf3); 120.7 (Cg); 113.4
(Cf2)
Tyr 22
1H 4.58 3.11; 2.96 7.12 6.81 (He)
13C 56.7 36.9 131.8 117.1 (Ce)
Tyr 27
1H 4.35 3.03; 2.87 7.02 6.78 (He)
13C 56.7 38.1 132.0 116.9 (Ce)
Cys a




13C4 1 . 0
Letters a, b, c, d in the first column indicate the amino acid residues whose specific position in the peptide chains was not assigned.
doi:10.1371/journal.pone.0030739.t001
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distribution of RMSD values as a function of time shows that,
initially, Cupricyclin-1 underwent bigger conformational changes
than Cupricyclin-2 with respect to the starting conformation (see
Figure S5, top panel). However, analysis of the RMSD plots
indicates that, after the initial conformational changes occurred
during the equilibration period, Cupricyclin-1 remained more
stable than Cupricyclin-2 over the course of the production run
(lower fluctuations of the RMSD values; Figure S5, top panel). It is
noticeable in the RMSD plot that Cupricyclin-2 underwent a
reversible structural change during the period from 4.7 to 5.7 ns of
the unrestrained simulation.
Analysis of the matrix of Ca RMSD values of every frame with
respect to every other frame of the production run simulation (a
measure of the extent of conformational variability observed in the
system) shows that Cupricyclin-1 was represented by two distinct
clusters of conformations (see Figure S5, bottom panel A). A clear
structural rearrangement at around 4 ns of the unrestrained run
visible on the matrix representation coincides with a very small
increase of the values on the RMSD plot (Figure S5, top panel).
Analysis of the RMSD matrix of Cupricyclin-2 suggests that the
protein underwent several reversible transitions during the
simulation. Moreover, a higher similarity (lower RMSD values)
between the members of the same clusters of Cupricyclin-1 than
within the clusters of Cupricyclin-2 is observed (Figure S5, bottom
panel B).
From fluorescence quenching experiments a copper dissociation
constant of 10.7 (61.1)610
28 M was determined for Cupricyclin-
2, suggesting that a higher backbone flexibility causes a slight
decrease of the peptide affinity for copper ions. Optical
spectroscopy studies demonstrated that, also in the case of
Cupricyclin-2, addition of a stoichiometric amount of CuCl2
induces the appearance of absorption bands with maxima at 300–
312 nm and 520–600 nm which, by analogy with Cupricyclin-1,
were attributed to a Cu
2+-histidine charge-transfer band and to
electronic transitions of copper d-d orbitals typical of copper
complexes with nitrogen ligands, respectively [22,23]. The




Quite interestingly, the EPR spectrum of Cupricyclin-2 was
much less heterogeneous than that of Cupricyclin-1 (Fig. 6A, ‘‘Cc-
2’’ vs ‘‘Cc-1’’). However, both spectra appeared to be constituted
by the same species, although with different fractional contribu-
tions. As a matter of fact, a ‘‘pure’’ EPR lineshape was readily
obtained by subtracting a fraction of the Cupricyclin-1 lineshape
from the spectrum of Cupricyclin-2 (Fig. 6A, ‘‘diff’’). The
difference spectrum clearly showed at least nine superhyperfine
lines in the perpendicular region of the spectrum (Fig. 6B), with
position and average coupling constant (<14 G) typical of
copper(II) complexes with a minimum of four magnetically
equivalent histidine residues on the coordination plane, this result
being fully consistent with the body of our data. Again, the EPR
parameters were within a four nitrogens coordination sphere,
according to the Peisach-Blumberg plot [27].
Finally, the superoxide dismutase activity of Cupricyclin-2 was








determined for Cupricyclin-1 (Table 2). This result suggests that,
while a higher flexibility of the peptide backbone decreases the
stability of the copper site, the same flexibility may facilitate
coordination of both Cu
2+ and Cu
1+ within the same binding site
with positive effects on the copper reduction rate and thus on the
ability of the mini metalloprotein to act as a catalyst in redox
reactions.
Conclusions
The use of metal-binding peptides in green chemistry
applications and bioremediation is becoming an increasingly
adopted strategy [37]. This is due to the fact that small stable
scaffolds can be engineered to host a metal binding site starting
from basic structural principles [1]. On the other hand, the
insertion of metal binding residues can lead to a destabilization of
the scaffold and to undesired structural changes [1]. Knottins
represent one of the most stable scaffolds, being constrained by
three disulphide bonds, and are extremely tolerant to sequence
variation thus representing optimal candidates for redesign
strategies [4]. However the presence of three disulphide bonds
implies that the attainment of a unique structure during folding is
severely hampered by the possible formation of multiple disulphide
bonds isomers with a consequent low yield of the desired structural
form [18]. To overcome this problem, in this work we have
Table 2. Superoxide dismutase activity of Cupriknottins.




























Figure 7. Titration of Cupricyclin-1 with CuSO4 monitored by
1H NMR. The molar ratio CuSO4/Cupricyclin-1 is reported on the left
side of each spectrum.
doi:10.1371/journal.pone.0030739.g007
Redox-Active Redesigned Conotoxins
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e30739adopted the strategy of substituting the two knotted disulphides of
a member of the knottins family, v-conotoxin GVIA, with a
metal binding center. In this way it has been possible to obtain a
rigid metal-coordination environment while at the same time
avoiding the problems intrinsically connected with the presence
of multiple disulphide bonds. The redesigned peptides Cupricy-
clin-1 and -2 bind copper ions with a fairly high affinity and
display reversible reduction of the copper center, catalyzing the
dismutation of superoxide anions at an acceptable rate, compared
to other superoxide dismutase mimics [5,36]. One way of
improving the catalytic efficiency of Cupricyclins would be that
of mimicking the electrostatic potential distribution observed in
Cu,Zn superoxide dismutases in which a positively charged active
site is hosted in an essentially negatively charged protein surface
[38]. This gives rise to an electrostatic steering effect which makes
productive any collision of the substrate with the protein surface.
In fact the negatively charged substrate is repulsed by the
negatively charged protein surface and attracted by the positively
charged active site [38]. In this regard, it must be noted that the
C-terminal basic residues Lys24 and Arg25 of Cupricyclin-1
(Lys25 and Arg26 of Cupricyclin-2), according to the structural
models obtained by MD simulations, are located on the opposite
side of the copper solvent accessible site (Figure 3). These two
residues could be substituted by negatively charged ones thus
increasing the asymmetry of the electroststic potential distribution
of the two peptides and their electrostatic steering effect on the
substrate.
An additional issue that emerges from the results presented in
this work is the difficulty in reconciling structural rigidity with the
flexibility required to bind a metal ion in two different valence
states. As stated in the Results and Discussion section, the
imidazolate bridge that links the Cu and Zn ions in Cu,Zn SOD
results in a distorted tetrahedral structure of the copper site which
is crucial for high SOD activity [31,32]. The same geometry
cannot be reproduced in our design making the copper
environment in Cupricyclins significantly more rigid and resulting
in a relatively low SOD activity. From this viewpoint, it is known
that mononuclear metal centers based on iron, manganese and
nickel display superoxide dismutase activity [39]. MnSOD, in
particular, in which the metal ion is coordinated by one Asp and
three His residues [39] appears to be a good model for future
developments of our design. Further studies will be required to
address this point and obtain high affinity metal binding peptides
endowed with faster redox kinetics.
Materials and Methods
Molecular modelling
Initial structural models of Cupricyclin-1 and Cupricyclin-2
were built using the average solution structure of v-conotoxin
GVIA as a template (PDB code 2CCO [14]). The conformation of
the inserted His residues was chosen using the standard Deep
View rotamer library [40] so as to form a tetragonal metal binding
site with geometry and ligand distances comparable to the copper
binding site of bovine Cu,Zn superoxide dismutase (PDB code
2SOD [19]).
Molecular dynamics simulations
All simulations were performed with the GROMACS (v. 4.0.7)
simulation package [41] together with the Amber99SB force field
[42]. The parameter sets were generated by the tleap program of
the Amber (v.9) molecular dynamics package [43]. The conversion
into the GROMACS topology was performed by the Perl script
amb2gmx.pl [44]. Lennard-Jones parameters (Rmin/2=1.0330 A ˚,
e=0.0427 kcal/mol) published by C. S. Babu and C. Lim were
chosen for the copper ion [45].
Copper-coordinating residues (His8, His15, His19, His26 of
Cupricyclin-1, and His8, His15, His20, His27 of Cupricyclin-2)
were protonated at the Nd1 position. Each molecule was placed in
a rhombic dodecahedron box. The size of the simulation boxes
was chosen to satisfy the condition that the distance between any
protein atom and the box boundaries was larger than 1 nm. The
simulation boxes were solvated with SPC/E [46] water molecules
and neutralized with Cl
2 ions. The solvated molecules were
energy minimized by using the Steepest Descent algorithm until
the convergence criterion of 100 kJ mol
21 nm
21 was reached
(approx. 4000 steps for Cupricyclin-1 and 5100 steps for
Cupricyclin-2). During the minimization runs position restraints
of 1,000 kJ mol
21 nm
22 were applied to all non-hydrogen atoms
of the proteins, except for copper-binding residues. The distances
between the copper ion and the Ne2 atoms of the 4 coordinating
histidine residues of each molecule were restrained to a value of
0.2 nm by using a harmonic potential of 100,000 kJ mol
21 nm
22
(bond type 6 of the GROMACS topology). 100 ps molecular
dynamics simulation under NVT conditions, followed by 100 ps
NPT simulation, with position restraints on all heavy atoms of the
proteins and with restrained copper-ligand binding distances, were
performed in order to equilibrate the temperature and pressure
values of the systems. In the following two steps the structures were
submitted to a 5 ns molecular dynamics simulation with harmonic
potentials applied only to the distances between copper and its
ligands and finally to a 10 ns simulation without any restraint.
A constant temperature value of 298 K was maintained during
the simulations with the V-rescale algorithm [47], with a coupling
constant of 0.1 ps. Parrinello-Rahman barostat [48] with a
coupling constant of 2.0 ps was used for pressure coupling. The
simulations were performed with a time step of 2 fs. Lennard-
Jones interactions were cut off at 1.0 nm. Particle-mesh Ewald
method (PME) [49] was applied to electrostatic interactions with a
real space cutoff of 1.0 nm. All bonds, except those of water
molecules, were constrained with the LINCS algorithm [50]. The
SETTLE algorithm [51] was used for water molecules.
Peptides synthesis
Cupricyclins were synthesised by standard Fmoc chemistry on
an automated Peptide Synthesizer (Pioneer, Applied Biosystems).
The protected peptides were grown on a PAL-resin with a high
level of modification, using the HATU/DIPEA amino acid
activation, according to manufacturer’s instructions. Side chain
protection scheme was the following: Asp(Ot-Bu), Cys(Trt),
Trp(Boc) and Lys(t-Boc). After synthesis, both peptides were
released and deprotected by treatment with TFA/H2O/triisopro-
pylsilane (90:5:5 by volume) for 1 hr at room temperature. The
cleavage mixture was filtered under vacuum into t-butyl-methyl
ether at 220uC. Peptides were collected by centrifugation at
2500 rpm for 20 min at 4uC and washed with t-butyl-methyl
ether. The pellet was dissolved in 50% acetonitrile and lyophilized.
Peptides were loaded on a Vydac C18 semipreparative column
(10 mm6250 mm, 5 mm particle size, 300 A ˚ pore size) and
isolated from by-products with an HPLC apparatus (model
K1001, Knauer GmbH, Berlin, Germany), using a linear gradient
of 5–80% acetonitrile, containing 0.2% TFA, in 60 min. Elution
was monitored by absorbance at 230 nm with an on-line UV
detector (model K2501, Knauer GmbH, Berlin, Germany) and
peptide fractions were manually collected. The major peptide-
containing fractions were air oxidized at 0.01% concentration (w/
w) by magnetic stirring in 0.1 M NH4HCO3 for 30 min at room
temperature. The cyclic peptides were finally purified from
Redox-Active Redesigned Conotoxins
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synthetic products (see above), and characterized by infusion in an
electrospray mass spectrometry (ES-IT, mod. LCQ, ThermoElec-
tron, San Jose, CA, USA).
Fluorescence quenching experiments
Fluorescence spectra of Cupricyclins were recorded at room
temperarure with a Jasco FP-6200 spectrofluorometer. The
excitation wavelength was 280 nm and the excitation and emission
slits were set at 10 and 5 nm, respectively. Emission spectra were
recorded in the 320 to 400 nm range. Peptides were dissolved at a
concentration of 4.9610
27 M in 50 mM sodium acetate buffer
(pH 6.5). For copper binding studies, CuCl2 (6.2610
26 M) was
added in aliquots and fluorescence was measured after 5 min after
addition. The dissociation constant values given in the text are the
average of at least three independent experiments.
Optical spectroscopy
UV-Vis electronic absorption spectra were recorded on an
Perkin-Elmer l14P spectrophotometer. Protein concentration was
determined by UV absorption at 280 nm, by using a molar




Low temperature X-band EPR spectra were recorded on a
Bruker ECS 106 spectrometer equipped with an ER4111VT
temperature controller. In detail, spectra were recorded at
9.556 GHz and 115 K. Cupricyclins concentration was 0.5 mM
in 50 mM sodium acetate buffer, pH 6.5.
NMR spectroscopy
NMR spectra were recorded at 300 K on a Bruker AVANCE
AQS 600 spectrometer operating at 600.13 MHz and equipped
with a Bruker multinuclear z-gradient probehead. Peptide solution
was prepared in H2O with 10% of D2O (v/v). pH values of
Cupricyclin-1 solution was adjusted to 8.0 by the addition of
0.1 M NaOH in D2O to deprotonate the N-H/N-D group of the
imidazole ring of histidine residues. In all the
1H spectra, a soft
presaturation of the HOD residual signal was applied.
Superoxide dismutase activity assay
Superoxide dismutase activity of Cupricyclins was determined
using the pyrogallol enzymatic assay [34]. The assay was carried
out at 30uC, in 20 mM Tris-HCl buffer pH 8.2, containing 1 mM
EDTA and 200 mM pyrogallol, recording the absorption increase
at 420 nm for 3 min. Bovine erythrocytes Cu,Zn superoxide
dismutase (0.1 mM in 20 mM Tris HCl buffer pH 8.2) was used as
a standard.
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